Intecept Pharma Shares Spike To Session High On Volume As Hearing RBC Commented On Recent Co. CEO Communication With FDA, Definitive Confirmation Histological Endpoints Can Still Form Basis Of Accelerated Approval From Its REVERSE Study
Benzinga Newsdesk